MIT

10 pharmas form nonprofit TransCelerate to accelerate R&D of new medicines

Wednesday, September 19, 2012 02:46 PM

Ten biopharmaceutical companies have formed a non-profit organization, TransCelerate BioPharma, to accelerate the development of new medicines. Participants include Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Pfizer, Genentech and Sanofi.

More... »

DART Therapeutics appoints executive team

Friday, September 14, 2012 01:51 PM

DART Therapeutics, a Cambridge, Mass.-based new-model biotechnology firm focused on developing therapies for Duchenne Muscular Dystrophy (DMD), has appointed an executive team. Members include co-founder and executive chairman Eugene W. Williams with the new title of CEO, Ernest D. Bush, PhD, as chief scientific officer., Dr. Elliot Goldstein as chief medical officer, and Cabot Brown as chief financial officer.

More... »

Abbott, Astellas collaborate on CMV vaccine trial

Monday, September 10, 2012 11:03 AM

Abbott has signed an agreement to collaborate with Astellas Pharma Global Development in a phase III clinical trial for ASP0113 (TransVax), an investigational vaccine licensed from Vical for preventing cytomegalovirus (CMV) reactivation in transplant patients.

More... »

United Drug acquires Bilcare’s clinical trials materials business

Monday, August 20, 2012 11:51 AM

United Drug, an international provider of healthcare services, will acquire the U.K. and U.S. clinical services businesses (combined "Bilcare Global Clinical Supplies" or "Bilcare GCS") from Bilcare Limited for $61 million. The acquisition is expected to be completed on Aug. 31. Bilcare will retain its clinical supplies business in Asia.

More... »

CROS NT appoints MacGarvey as vice president

Wednesday, August 15, 2012 02:01 PM

CROS NT, an international CRO specializing in clinical data services, has appointed Andrew MacGarvey as the vice president of U.K. and U.S. operations.

More... »

Genentech and Novartis rank as image leaders among oncologists, hematologists

Wednesday, July 25, 2012 09:59 AM

Genentech and Novartis have the best image among oncologists and hematologists, according to Market Strategies International, a market research consultancy that recently completed its 2012 Oncology Image Study.

More... »

GSK to acquire Human Genome Sciences for $14.25 per share in cash

Monday, July 16, 2012 10:51 AM

GlaxoSmithKline and Human Genome Sciences have announced a definitive agreement under which GSK will acquire HGS for $14.25 per share in cash.

More... »

MIT nutrient mixture improves memory in early Alzheimer’s

Tuesday, July 10, 2012 10:04 AM

An MIT clinical trial of an Alzheimer’s disease treatment has found that the nutrient cocktail can improve memory in patients with early Alzheimer’s. The results confirm and expand the findings of an earlier trial of the nutritional supplement, which is designed to promote new connections between brain cells.

More... »

Shionogi launches new European headquarters in London

Friday, July 6, 2012 11:47 AM

Japan-based pharmaceutical company Shionogi & Co. has launched its new European headquarters in London, to be called Shionogi Limited.

More... »

GSK, Theravance report positive results from four phase III COPD studies

Monday, July 2, 2012 03:09 PM

GlaxoSmithKline and Theravance, a biopharmaceutical company based in San Francisco, issued results from four pivotal phase III studies of investigational LAMA/LABA involving over 4,000 patients with chronic obstructive pulmonary disease (COPD).

More... »